You just read:

Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017

News provided by

Neurotrope, Inc.

Jul 19, 2017, 11:16 ET